When Reserved List appreciation is all but guaranteed, could taking out a loan to spec on them be profitable? David looks at a case study of someone who did just that.

Rob likes how our featured card is positioned in today’s market. Find out here why!

Rob is back with another mythic rare from Battlebond.

The banning of Deathrite Shaman may be the most significant in Legacy history. How will this impact the marketplace – and which cards should we be buying?

Rob returns this week with one of his favorite picks from Battlebond!

Adam covers the major market news and trends of the past week, including the Commander Anthologies V. 2 decklists being revealed and more Reserved List spikes.

Rob’s here to go over the calls he’s made writing the Daily Stock Watch – what worked, what didn’t, what did he learn, and how can you profit from the knowledge?

Last weekend the Grand Prix double-header in Seattle had a big impact on the market, and today Adam has all the details.

Reprints seem to follow a predictable trajectory every time. Sig examines the three stages of a reprint’s price curve and identifies some cards that may be solid pickups right now.

Rob thinks it’s time for you to go all in on this all-time classic reliable. Read more about it here!

Rob continues his analysis of some heavy hitters from Masters 25.

This year in MTG finance turned out great if you had the right exposure, but some formats floundered. Could things change in 2018? Sig makes his predictions for 2018.